Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nucleic Acid Ther ; 21(6): 423-36, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22196370

ABSTRACT

The toll-like receptors (TLRs) 7, 8, and 9 stimulate innate immune responses upon recognizing pathogen nucleic acids. Certain GU- or AU-rich RNA sequences were described to differentiate between human TLR7- and TLR8-mediated immune effects. Those single-stranded RNA molecules require endosomal delivery for stabilization against ribonucleases. We have discovered RNA sequences that preferentially activate TLR7, form higher ordered structures, and do not require specific cellular delivery. In addition, a dual activation of TLR8 and TLR9 without affecting TLR7 can be achieved by chimeric molecules consisting of GU-rich RNA and Cytosin (C) phosphordiester or phosphorthioat (p) guanine (CpG) motif DNA sequences. Such chimeras stimulate TLR9-mediated type I interferon (IFN) and TLR8-depending proinflammatory cytokine and chemokine production upon primary human cell activation. However, an RNA-dependent TLR7 IFN-α cytokine release is suppressed by the phosphorothioate DNA sequence contained in the chimeric molecule. To convert the immune response of a single-stranded RNA from TLR7/8 to TLR9, a simple chemical modification at the 5' end proves to be sufficient. Such 8-oxo-2'-deoxy-guanosine or 8-bromo-2'-deoxy-guanosine modifications of the first guanosine in GU-rich single-stranded RNAs convert the immune response to include TLR9 activation and demonstrate strong additive effects for type I IFN immune responses in human primary cells.


Subject(s)
Oligoribonucleotides/administration & dosage , Oligoribonucleotides/chemistry , Toll-Like Receptor 7/drug effects , Toll-Like Receptor 8/drug effects , Toll-Like Receptor 9/drug effects , Animals , Cells, Cultured , Chemokines/drug effects , Cytokines/drug effects , Female , HEK293 Cells/drug effects , HEK293 Cells/immunology , Humans , Immunity, Innate/drug effects , Interferon Type I/drug effects , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/immunology , Male , Mice , Phosphorothioate Oligonucleotides/administration & dosage , Phosphorothioate Oligonucleotides/chemistry , Toll-Like Receptor 7/immunology , Toll-Like Receptor 8/immunology , Toll-Like Receptor 9/immunology
2.
J Endotoxin Res ; 10(6): 431-8, 2004.
Article in English | MEDLINE | ID: mdl-15588427

ABSTRACT

Several classes of CpG oligodeoxynucleotides (ODNs) with different immune stimulatory profiles were recently identified: the A-, B- and C-classes. In this study, we investigated the CpG-dependent stimulation of IFN-gamma-inducible protein 10 (IP-10 or CXCL10) in different human immune cell types. CpG ODNs induced IP-10 in monocytes, pDCs and in B cells. Purified B cells as well as RPMI 8226 cells responded to CpG stimulation by IP-10 production. Treatment with exogenous IFN-alpha2b sensitized PBMCs, purified B cells as well as RPMI 8226 cells to respond more efficiently to stimulation with CpG ODNs by IP-10 production. IP-10 signaling could be directly stimulated via TLR9 in CpG-unresponsive HEK293 cells transfected with human TLR9 and an IP-10 reporter construct. Therefore, CpG-mediated IP-10 production is stimulated through IFN-alpha in cells that express the IFN-alpha receptor, a second pathway for IP-10 induction exists in TLR9-expressing B cells and pDCs where IP-10 is stimulated directly upon CpG-mediated TLR9 signaling. Our data provide a better understanding of the mechanisms through which CpG ODNs induce efficient Th1 responses.


Subject(s)
Adjuvants, Immunologic/pharmacology , B-Lymphocytes/drug effects , Chemokines, CXC/biosynthesis , CpG Islands/immunology , Oligodeoxyribonucleotides/pharmacology , B-Lymphocytes/immunology , Cells, Cultured , Chemokine CXCL10 , DNA Primers/chemistry , Dendritic Cells/drug effects , Dendritic Cells/immunology , Dose-Response Relationship, Drug , Humans , Interferon alpha-2 , Interferon-alpha/pharmacology , Interferon-gamma/pharmacology , Kidney/drug effects , Kidney/metabolism , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/immunology , Membrane Glycoproteins/metabolism , Monocytes/drug effects , Monocytes/immunology , Oligodeoxyribonucleotides/classification , Receptor, Interferon alpha-beta , Receptors, Cell Surface/metabolism , Receptors, Interferon/metabolism , Recombinant Proteins , Toll-Like Receptor 9 , Toll-Like Receptors , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...